Culturing Caco-2 cells is considered the reference in vitro technique to evaluate gastrointestinal permeability during novel drug discovery phases, according to leading regulatory agencies (FDA, EMA and PMDA) and can easily be adapted for high-throughput screening of compounds.
The primary outcome of such technique is the transport rate of the experimental compound across the Caco-2 monolayer membrane, which positively predicts in vivo absorption across the intestinal system into the bloodstream thanks to the well-established correlation between the in vitro system and the physiologic intestinal absorption.
Speciallized culture procedure
The Caco-2 cells incorporated in the CacoReady Kit are seeded on transwell inserts with semi-porous polycarbonate filter providing independent access to both sides of the cell monolayers (donor-receiver or apical-basal compartments) that mimic the intestinal lumen and the blood circulation, respectively. The cells are cultured at 37ºC for 15 days, applying culture medium changes every second day to allow the formation of a confluent monolayer.
CacoReady can be delivered in 24-well and 96-well/plate with shipping medium, a gel-like cell culture medium established by Readycell, which ensures the viability of Caco-2 cells and enables the transport of cells at room temperature worldwide in a ready-to-use format.
Which are the key steps to perform a successful in vitro permeability assay with CacoReady?
- Assessment of cell monolayer integrity
In order to verify that cell integrity meet the standards, Transepithelial Electrical Resistance (TEER), apparent permeability coefficient (Papp) and paracellular flux index (LY) can be assessed. The acceptance criterion after 21 days of differentiation are:
|Measurement||Cacoready® 24w||CacoReady® 96w|
|TEER||> 1000 Ω·cm2||> 500 Ω·cm2|
|LY apparent permeability (Papp)||≤ 1 x 10-6 cm/s||≤ 1 x 10-6 cm/s|
|LY Paracellular Flux||≤ 0.5%||≤ 0.7%|
- Test compound permeability assay
CacoReady allows conducting permeability assays (apical to basal or basal to apical) of established or unknown compounds to predict their absorption and interaction with membrane-associated proteins (MDR1-Pgp and BCRP). It is recommended to perform the assay for 2h and assess each compound in triplicate in the A-B/B-A directions at initial 10 µM concentration suggested for unknowns.
Compounds concentration may be analyzed by mass spectrometry according to the suitable analytical procedures.
- Reference Compounds for Permeability Studies
Several compounds can be used as control tests; the main recommendation is to validate the assay using a high permeable molecule, such as Propanolol, and a low permeability compound, such as Atenolol, in triplicates for each group.
Low permeability substrate
High permeability substrate
MDR1 (Pgp) substrate
MDR1 (Pgp) inhibitor
- Evaluation of the Compound Permeability
The apparent permeability coefficient (Papp) is calculated from the permeation rate and compound concentration at t=0h and t=2h.
dQ/dt: amount of product present in the basal (A-B) or apical (B-A) compartment as a function of time (nmol/s).
A: area of transwell (cm2).
C0: initial concentration of product applied in the apical (A-B) or basal (B-A) compartment (nmol/ml).
- In vivo Absorption extrapolation
Based on in vitro/in vivo correlation studies, Papp values obtained from Caco-2 barrier studies are used to define and predict the intestinal permeability of the tested compounds.
|In vitro Papp values||Range of predicted in vivo absorption|
|Papp ≤ 10-6 cm/s||Low (0-20%)|
|10-6cm/s < Papp ≤ 10 x 10-6 cm/s||Medium (20-70%)|
|Papp > 10 x 10-6 cm/s||High (70-100%)|
To learn more about the cell models used in permeability testing, as well as the products indicated for this purpose, you can consult the following web page.
In case it is required more specific information related to Caco-2 permeability studies and CacoReady kits, you can contact us through our form or sending an email at email@example.com